mannose has been researched along with Bowel Diseases, Inflammatory in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Alaeddine, M; Alric, L; Auffret, Y; Authier, H; Benmoussa, K; Bernad, J; Bertrand, B; Bruno-Bonnet, C; Coste, A; Jacquemin, G; Parny, M; Prat, M; Rahabi, M; Robert-Jolimaître, P; Salon, M | 1 |
| Chen, K; Chen, Z; Dong, L; He, J; Jiang, H; Li, D; Liu, Y; Lu, X; Wang, J; Wang, Q; Wang, XY; Wang, Y; Xie, J; Zhang, L; Zhou, J; Zou, X; Zuo, D | 1 |
| Abdalla, M; Chi, Z; Hamouda, HI; Liu, C; Shabana, S; Sharaf, M | 1 |
| Cao, Q; Cheng, H; Guo, K; Hu, Z; Ke, Y; Lang, J; Mertens, RT; Pan, T; Shen, M; Xiao, P; Zhang, H; Zhang, X | 1 |
| Li, X; Luo, L; Pan, Q; Wang, YP; Yuan, CH; Zhang, DL; Zhang, XL; Zhou, KL | 1 |
| Arif, M; Chi, Z; Li, G; Liu, CG; Sun, Q | 1 |
| Chokshi, NV; Khatri, HN; Patel, BM; Patel, MM; Rawal, SU; Shah, NN; Sinhmar, GK | 1 |
| Ayyadurai, S; Charania, MA; Laroui, H; Merlin, D; Viennois, E; Xiao, B; Zhang, Y | 1 |
| Barnich, N; Bernard, J; Bilyy, R; Borsali, R; Bouckaert, J; Crepet, A; Darfeuille-Michaud, A; Deniaud, D; Dumych, T; Fleury, E; Gouin, SG; Li, Z; Sivignon, A; Travelet, C; Yamakawa, N; Yan, X | 1 |
| Merlin, D; Si, XY; Xiao, B | 1 |
| Brayden, DJ; Coco, R; Jérôme, C; Plapied, L; Pourcelle, V; Préat, V; Schneider, YJ | 1 |
1 review(s) available for mannose and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease.
Topics: Administration, Oral; Animals; Cell Nucleus; Drug Carriers; Endosomes; Epithelium; Fusion Regulatory Protein-1; Galactose; Gastrointestinal Tract; Humans; Hyaluronic Acid; Hydrogels; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Mannose; Nanoparticles; Permeability; Pharmaceutical Preparations; Reactive Oxygen Species; Receptors, Transferrin | 2016 |
10 other study(ies) available for mannose and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Bioactive fish collagen peptides weaken intestinal inflammation by orienting colonic macrophages phenotype through mannose receptor activation.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Collagen; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Inflammatory Bowel Diseases; Macrophages; Mannose; Mannose Receptor; Mice; Mice, Inbred C57BL; Peptides; Phenotype | 2022 |
Mannose ameliorates experimental colitis by protecting intestinal barrier integrity.
Topics: Animals; Caco-2 Cells; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mannose; Mice; Mice, Inbred C57BL; Tight Junctions | 2022 |
Multifunctional nanoparticles based on marine polysaccharides for apremilast delivery to inflammatory macrophages: Preparation, targeting ability, and uptake mechanism.
Topics: Caco-2 Cells; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Macrophages; Mannose; Multifunctional Nanoparticles; Nanoparticles; Polysaccharides | 2022 |
Mannose metabolism normalizes gut homeostasis by blocking the TNF-α-mediated proinflammatory circuit.
Topics: Animals; Colitis; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mannose; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha | 2023 |
Mannose-capped lipoarabinomannan-induced B10 cells decrease severity of dextran sodium sulphate-induced inflammatory bowel disease in mice.
Topics: Animals; B-Lymphocytes, Regulatory; Dextran Sulfate; Disease Models, Animal; Humans; Immune Tolerance; Inflammatory Bowel Diseases; Interleukin-10; Lipopolysaccharides; Mannose; Mice; Mice, Knockout; Mycobacterium tuberculosis; Th1 Cells | 2020 |
Macrophages-targeting mannosylated nanoparticles based on inulin for the treatment of inflammatory bowel disease (IBD).
Topics: Animals; Caco-2 Cells; Cell Line, Tumor; China; Colitis; Drug Carriers; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Inulin; Macrophages; Male; Mannose; Mice; Mice, Inbred BALB C; Nanoparticles; RAW 264.7 Cells | 2021 |
Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease.
Topics: Body Weight; Budesonide; Cell Line; Cell Survival; Colon; Drug Carriers; Drug Liberation; Engineering; Humans; Inflammatory Bowel Diseases; Kinetics; Lipids; Mannose; Nanoparticles; Organ Size; Surface Properties | 2018 |
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.
Topics: Animals; Caco-2 Cells; Cell Death; Electrophoresis, Agar Gel; Endocytosis; Humans; Inflammatory Bowel Diseases; Macrophages; Magnetic Resonance Spectroscopy; Male; Mannose; Mice; Nanoparticles; Particle Size; Polymers; Polyphosphates; RNA Interference; RNA, Small Interfering; Titrimetry; Tumor Necrosis Factor-alpha | 2013 |
Glycopolymers as Antiadhesives of E. coli Strains Inducing Inflammatory Bowel Diseases.
Topics: Adhesins, Escherichia coli; Animals; Cell Adhesion; Escherichia coli; Fimbriae Proteins; HeLa Cells; Heptanol; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mannose; Mice; Polysaccharides, Bacterial | 2015 |
Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
Topics: Animals; Caco-2 Cells; Chitosan; Colitis; Cytokines; Dextran Sulfate; Drug Carriers; Ethylene Oxide; Female; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Lactic Acid; Lactones; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Ovalbumin; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids | 2013 |